Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4826030, 14 pages
https://doi.org/10.1155/2017/4826030
Research Article

Computational Identification and Characterization of a Promiscuous T-Cell Epitope on the Extracellular Protein 85B of Mycobacterium spp. for Peptide-Based Subunit Vaccine Design

1Department of Biotechnology, Faculty of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan
2Department of Genetic Engineering & Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh
3Department of Dermatology, Sylhet Women’s Medical College, Sylhet 3114, Bangladesh

Correspondence should be addressed to Abul Kalam Azad; ude.tsus@ctb-dazakad

Received 25 October 2016; Revised 25 January 2017; Accepted 26 February 2017; Published 16 March 2017

Academic Editor: Marcela I. Henao-Tamayo

Copyright © 2017 Md. Saddam Hossain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Tuberculosis Report 2013, World Health Organization, Geneva‎, Switzerland, 2013.
  2. World Health Organization, WHO Report. Global Tuberculosis Control 2011, World Health Organization, Geneva, Switzerland, 2013.
  3. S. T. Cole, R. Brosch, J. Parkhill et al., “Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence,” Nature, vol. 393, no. 6685, pp. 537–544, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. Ĩ. Comas, J. Chakravartti, P. M. Small et al., “Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved,” Nature Genetics, vol. 42, no. 6, pp. 498–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Achtman, “Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens,” Annual Review of Microbiology, vol. 62, pp. 53–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Comas, S. Homolka, S. Niemann, and S. Gagneux, “Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies,” PLoS ONE, vol. 4, no. 11, Article ID e7815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Hershberg, M. Lipatov, P. M. Small et al., “High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography,” PLoS Biology, vol. 6, no. 12, pp. 2658–2671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Comas, M. Coscolla, T. Luo et al., “Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans,” Nature Genetics, vol. 45, no. 10, pp. 1176–1182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Firdessa, S. Berg, E. Hailu et al., “Mycobacterial lineages causing pulmonary and extrapulmonary Tuberculosis, Ethiopia,” Emerging Infectious Diseases, vol. 19, no. 3, pp. 460–463, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Gagneux, K. DeRiemer, T. Van et al., “Variable host-pathogen compatibility in Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2869–2873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Hirsh, A. G. Tsolaki, K. DeRiemer, M. W. Feldman, and P. M. Small, “Stable association between strains of Mycobacterium tuberculosis and their human host populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4871–4876, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. B. Reed, V. K. Pichler, F. Mcintosh et al., “Major Mycobacterium tuberculosis lineages associate with patient country of origin,” Journal of Clinical Microbiology, vol. 47, no. 4, pp. 1119–1128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. E. M. Fine, “Variation in protection by BCG: implications of and for heterologous immunity,” The Lancet, vol. 346, no. 8986, pp. 1339–1345, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. A. C. Hesseling, B. J. Marais, R. P. Gie et al., “The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children,” Vaccine, vol. 25, no. 1, pp. 14–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. E. Weir, G. F. Black, B. Nazareth et al., “The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette–Guérin vaccination in southern England and northern Malawi,” Clinical and Experimental Immunology, vol. 146, no. 3, pp. 390–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. K. Azad, N. Yoshikawa, T. Ishikawa, Y. Sawa, and H. Shibata, “Substitution of a single amino acid residue in the aromatic/arginine selectivity filter alters the transport profiles of tonoplast aquaporin homologs,” Biochimica et Biophysica Acta—Biomembranes, vol. 1818, no. 1, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. V. Tullius, G. Harth, S. Masleša-Galić, B. J. Dillon, and M. A. Horwitz, “A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG,” Infection and Immunity, vol. 76, no. 11, pp. 5200–5214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. F. Hoft, “Tuberculosis vaccine development: goals, immunological design, and evaluation,” The Lancet, vol. 372, no. 9633, pp. 164–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. H. M. Ottenhoff and S. H. E. Kaufmann, “Vaccines against tuberculosis: where are we and where do we need to go?” PLoS Pathogens, vol. 8, no. 5, Article ID e1002607, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Kaufmann, G. Hussey, and P.-H. Lambert, “New vaccines for tuberculosis,” The Lancet, vol. 375, no. 9731, pp. 2110–2119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Davila, L. A. McNamara, and Z. Yang, “Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85b-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach,” PLoS ONE, vol. 7, no. 7, Article ID e40882, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. McNamara, Y. He, and Z. Yang, “Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis,” BMC Immunology, vol. 11, article no. 18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Brennan and J. Thole, “Tuberculosis vaccines: a strategic blueprint for the next decade,” Tuberculosis, vol. 92, no. 1, pp. S6–S13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Marmiesse, P. Brodin, C. Buchrieser et al., “Macro-array and bioinformatic analyses reveal mycobacterial “core” genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex,” Microbiology, vol. 150, no. 2, pp. 483–496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Sreevatsan, X. Pan, K. E. Stockbauer et al., “Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9869–9874, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Filliol, A. S. Motiwala, M. Cavatore et al., “Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set,” Journal of Bacteriology, vol. 188, no. 2, pp. 759–772, 2006. View at Google Scholar
  27. A. M. Hebert, S. Talarico, D. Yang et al., “DNA polymorphisms in the pepA and PPE18 genes among clinical strains of Mycobacterium tuberculosis: implications for vaccine efficacy,” Infection and Immunity, vol. 75, no. 12, pp. 5798–5805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. V. S. Hill, C. E. M. Allsopp, D. Kwiatkowski et al., “Common West African HLA antigens are associated with protection from severe malaria,” Nature, vol. 352, no. 6336, pp. 595–600, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Howard, “Disease and evolution,” Nature, vol. 352, no. 6336, pp. 565–567, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Copin, M. Coscollá, S. N. Seiffert et al., “Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition,” mBio, vol. 5, no. 1, Article ID e00960-13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Blackwell, S. E. Jamieson, and D. Burgner, “HLA and infectious diseases,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 370–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Brandt, M. Elhay, I. Rosenkrands, E. B. Lindblad, and P. Andersen, “ESAT-6 subunit vaccination against Mycobacterium tuberculosis,” Infection and Immunity, vol. 68, no. 2, pp. 791–795, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Sable, I. Verma, and G. K. Khuller, “Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis,” Vaccine, vol. 23, no. 32, pp. 4175–4184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. W. Olsen, L. A. H. Van Pinxteren, L. M. Okkels, P. B. Rasmussen, and P. Andersen, “Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6,” Infection and Immunity, vol. 69, no. 5, pp. 2773–2778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. He and Z. Xiang, “Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN,” Immunome Research, vol. 6, no. 1, article S5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. He, Z. Xiang, and H. L. T. Mobley, “Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 297505, 15 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. R. Kurtz, H. E. Petersen, D. R. Frederick, L. A. Morici, and J. B. McLachlan, “Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection,” Infection and Immunity, vol. 82, no. 6, pp. 2424–2433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Tu, B. Hou, B. Wang et al., “A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 5, pp. 401–408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. E. K. Jagusztyn-Krynicka, P. Roszczenko, and A. Grabowska, “Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development,” Polish Journal of Microbiology, vol. 58, no. 4, pp. 281–287, 2009. View at Google Scholar · View at Scopus
  40. Y. He, R. Rappuoli, A. S. De Groot, and R. T. Chen, “Emerging vaccine informatics,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 218590, 26 pages, 2010. View at Publisher · View at Google Scholar
  41. Z. Yang, J. Davila, L. Zhang, C. F. Marrs, and R. Durmaz, “Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 208371, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. W. Olsen, A. Williams, L. M. Okkels, G. Hatch, and P. Andersen, “Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model,” Infection and Immunity, vol. 72, no. 10, pp. 6148–6150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. T. van Dissel, S. M. Arend, C. Prins et al., “Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers,” Vaccine, vol. 28, no. 20, pp. 3571–3581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Yang, S. Sayers, Z. Xiang, and Y. He, “Protegen: a web-based protective antigen database and analysis system,” Nucleic Acids Research, vol. 39, S1, pp. D1073–D1078, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. I. A. Doytchinova and D. R. Flower, “VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines,” BMC Bioinformatics, vol. 8, no. 1, article 4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Notredame, D. G. Higgins, and J. Heringa, “T-coffee: a novel method for fast and accurate multiple sequence alignment,” Journal of Molecular Biology, vol. 302, no. 1, pp. 205–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Nielsen and O. Lund, “NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction,” BMC Bioinformatics, vol. 10, article 296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. M. Schuler, M.-D. Nastke, and S. Stevanović, “SYFPEITHI: database for searching and T-cell epitope prediction,” in Immunoinformatics: Predicting Immunogenicity In Silico, pp. 75–93, 2007. View at Google Scholar
  49. H. Singh and G. P. S. Raghava, “ProPred: prediction of HLA-DR binding sites,” Bioinformatics, vol. 17, no. 12, pp. 1236–1237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. M. V. Larsen, C. Lundegaard, K. Lamberth, S. Buus, O. Lund, and M. Nielsen, “Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction,” BMC Bioinformatics, vol. 8, no. 1, article 424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. F. F. Gonzalez-Galarza, S. Christmas, D. Middleton, and A. R. Jones, “Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations,” Nucleic Acids Research, vol. 39, supplement 1, pp. D913–D919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Gasteiger, C. Hoogland, A. Gattiker et al., Protein Identification and Analysis Tools on the ExPASy Server, Springer, Berlin, Germany, 2005.
  53. A. Patronov, I. Dimitrov, D. R. Flower, and I. Doytchinova, “Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach,” BMC Structural Biology, vol. 11, article 32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. H. M. Berman, J. Westbrook, Z. Feng et al., “The protein data bank,” Nucleic Acids Research, vol. 28, no. 1, pp. 235–242, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Totrov and R. Abagyan, “Flexible protein-ligand docking by global energy optimization in internal coordinates,” Proteins: Structure, Function and Genetics, vol. 29, no. 1, pp. 215–220, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. R. A. Laskowski, “PDBsum: summaries and analyses of PDB structures,” Nucleic Acids Research, vol. 29, no. 1, pp. 221–222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. J. M. Khan and S. Ranganathan, “PDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes,” Immunome Research, vol. 6, no. 1, article no. S2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Ben-Yedidia, H. Marcus, Y. Reisner, and R. Arnon, “Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection,” International Immunology, vol. 11, no. 7, pp. 1043–1051, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Ben-Yedidia and R. Arnon, “Towards an epitope-based human vaccine for influenza,” Human Vaccines, vol. 1, no. 3, pp. 95–101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Huet, D. F. Nixon, J. B. Rothbard, A. Townsend, S. A. Ellis, and A. J. Mcmichael, “Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27,” International Immunology, vol. 2, no. 4, pp. 311–316, 1990. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Suhrbier, C. Schmidt, and A. Fernan, “Prediction of an HLA B8-restricted influenza epitope by motif,” Immunology, vol. 79, no. 1, pp. 171–173, 1993. View at Google Scholar · View at Scopus
  62. M. V. Larsen, C. Lundegaard, K. Lamberth et al., “An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions,” European Journal of Immunology, vol. 35, no. 8, pp. 2295–2303, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. I. Dimitrov, P. Garnev, D. R. Flower, and I. Doytchinova, “MHC class II binding prediction—a little help from a friend,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 705821, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Wang, G. Xie, J. Liao et al., “Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice,” Virology Journal, vol. 8, article 232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Sette and J. Fikes, “Epitope-based vaccines: an update on epitope identification, vaccine design and delivery,” Current Opinion in Immunology, vol. 15, no. 4, pp. 461–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Ben-Yedidia and R. Arnon, “Epitope-based vaccine against influenza,” Expert Review of Vaccines, vol. 6, no. 6, pp. 939–948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Black, A. Trent, M. Tirrell, and C. Olive, “Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists,” Expert Review of Vaccines, vol. 9, no. 2, pp. 157–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Vita, J. A. Overton, J. A. Greenbaum et al., “The immune epitope database (IEDB) 3.0,” Nucleic Acids Research, vol. 43, no. D1, pp. D405–D412, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. J. McMurry, H. Sbai, M. L. Gennaro, E. J. Carter, W. Martin, and A. S. De Groot, “Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes,” Tuberculosis, vol. 85, no. 1-2, pp. 95–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. P. A. Reche, J.-P. Glutting, and E. L. Reinherz, “Prediction of MHC class I binding peptides using profile motifs,” Human Immunology, vol. 63, no. 9, pp. 701–709, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Shams, P. Klucar, S. E. Weis et al., “Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles,” Journal of Immunology, vol. 173, no. 3, pp. 1966–1977, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. U. Gowthaman and J. N. Agrewala, “In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion,” Journal of Proteome Research, vol. 7, no. 1, pp. 154–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Wang, J. Sidney, C. Dow, B. Mothé, A. Sette, and B. Peters, “A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach,” PLOS Computational Biology, vol. 4, no. 4, Article ID e1000048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. M. J. Blythe, Q. Zhang, K. Vaughan et al., “An analysis of the epitope knowledge related to Mycobacteria,” Immunome Research, vol. 3, no. 1, article 10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Contini, M. Pallante, S. Vejbaesya et al., “A model of phenotypic susceptibility to tuberculosis: deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 25, no. 1, pp. 21–28, 2008. View at Google Scholar · View at Scopus
  76. J. L. Flynn, “Immunology of tuberculosis and implications in vaccine development,” Tuberculosis, vol. 84, no. 1-2, pp. 93–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. J. L. Flynn and J. Chan, “Immunology of tuberculosis,” Annual Review of Immunology, vol. 19, pp. 93–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. D. A. Lewinsohn, E. Winata, G. M. Swarbrick et al., “Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B,” PLoS Pathogens, vol. 3, no. 9, article e127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. P. T. Tan, A. T. Heiny, O. Miotto et al., “Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines,” PLOS ONE, vol. 5, no. 1, Article ID e8754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. S. P. Ribeiro, D. S. Rosa, S. G. Fonseca et al., “A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules,” PLoS ONE, vol. 5, no. 6, Article ID e11072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. X. Lin, A. Sun, P. Ruan, Z. Zhang, and J. Yan, “Characterization of conserved combined T and B cell epitopes in leptospira interrogans major outer membrane proteins OmpL1 and LipL41,” BMC Microbiology, vol. 11, article 21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. M. M. Johnson and J. A. Odell, “Nontuberculous mycobacterial pulmonary infections,” Journal of Thoracic Disease, vol. 6, no. 3, pp. 210–220, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. T. K. Marras, P. Chedore, A. M. Ying, and F. Jamieson, “Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003,” Thorax, vol. 62, no. 8, pp. 661–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Martín-Casabona, A. R. Bahrmand, J. Bennedsen et al., “Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 10, pp. 1186–1193, 2004. View at Google Scholar · View at Scopus
  85. J. Van Ingen, S. A. Bendien, W. C. M. De Lange et al., “Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands,” Thorax, vol. 64, no. 6, pp. 502–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. J. E. Moore, M. E. Kruijshaar, L. P. Ormerod, F. Drobniewski, and I. Abubakar, “Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995–2006,” BMC Public Health, vol. 10, no. 1, article 612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. W.-J. Koh, O. J. Kwon, K. Jeon et al., “Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea,” Chest, vol. 129, no. 2, pp. 341–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. V. M. Katoch, “Infections due to non-tuberculous mycobacteria (NTM),” Indian Journal of Medical Research, vol. 120, no. 4, pp. 290–304, 2004. View at Google Scholar · View at Scopus
  89. R. J. Wallace Jr., R. O'brien, J. Glassroth, J. Raleigh, and A. Dutt, “Diagnosis and treatment of disease caused by nontuberculous mycobacteria,” American Review of Respiratory Disease, vol. 156, pp. S1–S25, 2012. View at Google Scholar
  90. H. C. Poyntz, E. Stylianou, K. L. Griffiths, L. Marsay, A. M. Checkley, and H. McShane, “Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis,” Tuberculosis, vol. 94, no. 3, pp. 226–237, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. C. B. Do and K. Katoh, “Protein multiple sequence alignment,” in Functional Proteomics: Methods and Protocols, pp. 379–413, Springer, 2008. View at Google Scholar
  92. B. J. McFarland and C. Beeson, “Binding interactions between peptides and proteins of the class II Major histocompatibility complex,” Medicinal Research Reviews, vol. 22, no. 2, pp. 168–203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. A. J. Sant, C. Beeson, B. McFarland et al., “Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange,” Immunological Reviews, vol. 172, pp. 239–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. V. Brusic, G. Rudy, M. Honeyman, J. Hammer, and L. Harrison, “Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network,” Bioinformatics, vol. 14, no. 2, pp. 121–130, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Zavala-Ruiz, I. Strug, M. W. Anderson, J. Gorski, and L. J. Stern, “A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins,” Chemistry & Biology, vol. 11, no. 10, pp. 1395–1402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Y. Arnold, N. L. La Gruta, T. Miller et al., “The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues,” The Journal of Immunology, vol. 169, no. 2, pp. 739–749, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. A. J. Godkin, K. J. Smith, A. Willis et al., “Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions,” Journal of Immunology, vol. 166, no. 11, pp. 6720–6727, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. T. G. Kimman, R. J. Vandebriel, and B. Hoebee, “Genetic variation in the response to vaccination,” Community Genetics, vol. 10, no. 4, pp. 201–217, 2007. View at Publisher · View at Google Scholar · View at Scopus